by Maria Zannes | Feb 4, 2021 | Press Releases
FEBRUARY 4, 2021 (SAN ANTONIO, TX) China’s leading healthcare company to evaluate bioAffinity’s non-invasive, highly accurate test for early-stage lung cancer with aim to commercialize in world’s largest market Shanghai Fosun Long March Medical Science Co., Ltd....
by Maria Zannes | Jan 27, 2021 | Events
Chief Medical & Science Officer Vivienne Rebel, MD, PhD, will present her poster “Automated Flow Cytometry Test Distinguishes Cancer from Non-Cancer in Sputum with High Sensitivity and Specificity” on January 28th through January 31st, 2021, at the International...
by Maria Zannes | Jan 27, 2021 | Articles
JANUARY 19, 2021 Contributed Commentary by Maria Zannes When it comes to cancer, there are many tools for cancer diagnosis, from initial screenings to invasive biopsies. The one selected depends on a number of factors, not the least of which is how the patient...
by Dale Harrison | Jan 16, 2021 | Publications
“Automated Flow Cytometry Test Distinguishes Cancer from Non-Cancer in Sputum with High Sensitivity and Specificity” International Association for the Study of Lung Cancer (IASLC) 2020 World Conference on Lung Cancer, Jan. 2021 Authors Lydia H. Bederka1,...
